These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 18209574

  • 1. Protective effects of carvedilol in murine model with the coxsackievirus B3-induced viral myocarditis.
    Yue-Chun L, Li-Sha G, Jiang-Hua R, Peng-Lin Y, Jia-Feng L, Ji-Fei T, Peng C, Zhan-Qiu Y.
    J Cardiovasc Pharmacol; 2008 Jan; 51(1):92-8. PubMed ID: 18209574
    [Abstract] [Full Text] [Related]

  • 2. Carvedilol treatment ameliorates acute coxsackievirus B3-induced myocarditis associated with oxidative stress reduction.
    Li YC, Ge LS, Yang PL, Tang JF, Lin JF, Chen P, Guan XQ.
    Eur J Pharmacol; 2010 Aug 25; 640(1-3):112-6. PubMed ID: 20457150
    [Abstract] [Full Text] [Related]

  • 3. Carvedilol improves left ventricular function in murine coxsackievirus-induced acute myocarditis association with reduced myocardial interleukin-1beta and MMP-8 expression and a modulated immune response.
    Pauschinger M, Rutschow S, Chandrasekharan K, Westermann D, Weitz A, Peter Schwimmbeck L, Zeichhardt H, Poller W, Noutsias M, Li J, Schultheiss HP, Tschope C.
    Eur J Heart Fail; 2005 Jun 25; 7(4):444-52. PubMed ID: 15921778
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of effects of ivabradine versus carvedilol in murine model with the Coxsackievirus B3-induced viral myocarditis.
    Yue-Chun L, Teng Z, Na-Dan Z, Li-Sha G, Qin L, Xue-Qiang G, Jia-Feng L.
    PLoS One; 2012 Jun 25; 7(6):e39394. PubMed ID: 22761780
    [Abstract] [Full Text] [Related]

  • 6. Carvedilol has stronger anti-inflammation and anti-virus effects than metoprolol in murine model with coxsackievirus B3-induced viral myocarditis.
    Wang D, Chen Y, Jiang J, Zhou A, Pan L, Chen Q, Qian Y, Chu M, Chen C.
    Gene; 2014 Sep 01; 547(2):195-201. PubMed ID: 24905653
    [Abstract] [Full Text] [Related]

  • 7. Cardioprotective effects of carvedilol on acute autoimmune myocarditis: anti-inflammatory effects associated with antioxidant property.
    Yuan Z, Shioji K, Kihara Y, Takenaka H, Onozawa Y, Kishimoto C.
    Am J Physiol Heart Circ Physiol; 2004 Jan 01; 286(1):H83-90. PubMed ID: 14684360
    [Abstract] [Full Text] [Related]

  • 8. Carvedilol increases the production of interleukin-12 and interferon-gamma and improves the survival of mice infected with the encephalomyocarditis virus.
    Nishio R, Shioi T, Sasayama S, Matsumori A.
    J Am Coll Cardiol; 2003 Jan 15; 41(2):340-5. PubMed ID: 12535832
    [Abstract] [Full Text] [Related]

  • 9. Effects of carvedilol treatment on cardiac cAMP response element binding protein expression and phosphorylation in acute coxsackievirus B3-induced myocarditis.
    Li-Sha G, Yi-He C, Na-Dan Z, Teng Z, Yue-Chun L.
    BMC Cardiovasc Disord; 2013 Nov 14; 13():100. PubMed ID: 24225056
    [Abstract] [Full Text] [Related]

  • 10. Ivabradine inhibits the production of proinflammatory cytokines and inducible nitric oxide synthase in acute coxsackievirus B3-induced myocarditis.
    Li YC, Luo Q, Ge LS, Chen YH, Zhou ND, Zhang T, Guan XQ, Lin JF.
    Biochem Biophys Res Commun; 2013 Feb 15; 431(3):450-5. PubMed ID: 23333383
    [Abstract] [Full Text] [Related]

  • 11. The mechanism of carvedilol in experimental viral myocarditis.
    Yue-Chun L, Li-Sha G, Xue-Qiang G, Jia-Feng L.
    Curr Pharm Des; 2012 Feb 15; 18(12):1620-4. PubMed ID: 22443630
    [Abstract] [Full Text] [Related]

  • 12. Cardioprotective effect of NO-metoprolol in murine coxsackievirus B3-induced myocarditis.
    Glück B, Dahlke K, Zell R, Krumbholz A, Decker M, Lehmann J, Wutzler P.
    J Med Virol; 2010 Dec 15; 82(12):2043-52. PubMed ID: 20981792
    [Abstract] [Full Text] [Related]

  • 13. Immunomodulation by interleukin-4 suppresses matrix metalloproteinases and improves cardiac function in murine myocarditis.
    Li J, Leschka S, Rutschow S, Schwimmbeck PL, Husmann L, Noutsias M, Westermann D, Poller W, Zeichhardt H, Klingel K, Tschope C, Schultheiss HP, Pauschinger M.
    Eur J Pharmacol; 2007 Jan 05; 554(1):60-8. PubMed ID: 17113076
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of verapamil on acute coxsackievirus B3 murine myocarditis.
    Xu Y, Yang YZ, Chen HZ, Jin PY, Guo Q, Zhao WZ, Yang JH, Cai QX, Zhou YC.
    Chin Med J (Engl); 1992 Oct 05; 105(10):818-21. PubMed ID: 1337875
    [Abstract] [Full Text] [Related]

  • 16. The heart-protective mechanism of Qishaowuwei formula on murine viral myocarditis induced by CVB3.
    Fengqin L, Yulin W, Xiaoxin Z, Youpeng J, Yan C, Qing-qing W, Hong C, Jia S, Lei H.
    J Ethnopharmacol; 2010 Feb 03; 127(2):221-8. PubMed ID: 19932162
    [Abstract] [Full Text] [Related]

  • 17. Myocardial protection by the novel vasodilating beta-blocker, carvedilol: potential relevance of anti-oxidant activity.
    Feuerstein GZ, Yue TL, Cheng HY, Ruffolo RR.
    J Hypertens Suppl; 1993 Jun 03; 11(4):S41-8. PubMed ID: 8104241
    [Abstract] [Full Text] [Related]

  • 18. Antiviral activity of coxsackievirus B3 3C protease inhibitor in experimental murine myocarditis.
    Yun SH, Lee WG, Kim YC, Ju ES, Lim BK, Choi JO, Kim DK, Jeon ES.
    J Infect Dis; 2012 Feb 01; 205(3):491-7. PubMed ID: 22207647
    [Abstract] [Full Text] [Related]

  • 19. Cytokine profiles in heart, spleen, and thymus during the acute stage of experimental coxsackievirus B3-induced chronic myocarditis.
    Schmidtke M, Glück B, Merkle I, Hofmann P, Stelzner A, Gemsa D.
    J Med Virol; 2000 Aug 01; 61(4):518-26. PubMed ID: 10897072
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.